Novavax | NVAX - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Adma Biologics USD 2.15B 2.19B 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Cassava Sciences USD 52M 30M 2026-07
Geron USD 955M 112M 2026-03
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
MannKind USD 757M 984M 2026-03
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Novartis USD 319.89B 31.63B 2026-07
Novavax USD 1.09B 316M 2025-12
Pfizer USD 153.81B 12.24B 2026-03
Sanofi EUR 100.27B 605.48M 2026-03
Sarepta Therapeutics USD 2.28B 30M 2026-03
TG Therapeutics USD 5.31B 572M 2026-03